BIO-RAD LABORATORIES, INC. Cash and Restricted Cash
BIO-RAD LABORATORIES, INC. (BIO.B) had Cash and Restricted Cash of $518.80 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $518.80M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $509.00M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $532.20M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $398.20M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $518.80M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $509.00M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $532.20M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $398.20M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $371.70M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $523.10M 10-Q · filed 2026-04-30 | |
| 2024-12-31 | $489.80M 10-Q · filed 2026-08-04 | |
| 2024-09-30 | $412.20M 10-Q · filed 2025-10-29 | $412.19M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $407.70M 10-Q · filed 2025-07-31 | $407.71M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $433.80M 10-Q · filed 2025-05-01 | $433.75M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $404.40M 10-K · filed 2026-02-13 | $404.37M 10-K · filed 2024-02-16 |
| 2023-09-30 | $458.31M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $390.48M 10-Q · filed 2024-08-02 | |
| 2023-03-31 | $464.50M 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $434.50M 10-K · filed 2026-02-13 | $434.54M 10-K · filed 2023-02-17 |
| 2022-09-30 | $518.24M 10-Q · filed 2023-10-27 | |
| 2022-06-30 | $596.91M 10-Q · filed 2023-08-04 | |
| 2022-03-31 | $802.66M 10-Q · filed 2023-05-05 | |
| 2021-12-31 | $471.10M 10-K · filed 2025-02-14 | $471.13M 10-K · filed 2022-02-11 |
| 2021-09-30 | $864.52M 10-Q · filed 2022-10-28 | |
| 2021-06-30 | $737.16M 10-Q · filed 2022-07-29 | |
| 2021-03-31 | $677.70M 10-Q · filed 2022-04-29 | |
| 2020-12-31 | $667.12M 10-K · filed 2024-02-16 | |
| 2020-09-30 | $845.10M 10-Q · filed 2021-10-29 | |
| 2020-06-30 | $612.13M 10-Q · filed 2021-07-30 | |
| 2020-03-31 | $608.44M 10-Q · filed 2021-04-30 | |
| 2019-12-31 | $662.65M 10-K · filed 2023-02-17 | |
| 2019-09-30 | $563.35M 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $583.37M 10-Q · filed 2020-07-31 | |
| 2019-03-31 | $458.54M 10-Q · filed 2020-05-08 | |
| 2018-12-31 | $434.16M 10-K · filed 2022-02-11 | |
| 2018-09-30 | $435.59M 10-Q · filed 2019-11-01 | |
| 2018-06-30 | $404.08M 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $407.64M 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $384.98M 10-K · filed 2021-02-16 | |
| 2017-09-30 | $330.04M 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $322.59M 10-Q · filed 2018-08-09 | |
| 2017-03-31 | $292.59M 10-Q · filed 2018-05-10 | |
| 2016-12-31 | $457.17M 10-K · filed 2020-03-02 | |
| 2015-12-31 | $458.82M 10-K · filed 2019-04-01 |